BERWYN, Pa., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other ...

“The future of bio health care is in medical services,” he said. “The aging population is the biggest crisis of the 21 century. If people start living up to 120 years, that’s going to create medical ...

BERWYN, Pa., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other ...

Berwyn, Pennsylvania--(Newsfile Corp. - September 3, 2021) - Annovis Bio, Inc. (NYSE American: ANVS), a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease ...

BERWYN, Pa., May 01, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease, Parkinson’s disease and other ...

Kim Hyun-woo, Seoul Bio Hub's director-general, plans to leverage the region’s rich talent pool to stretch beyond Korea's borders as the startup cluster prepares to launch the Global Center. “Looking ...

Hongneung is a quaint neighborhood in northeastern Seoul, situated near several universities and research institutes. In this area stands an organization working toward an ambitious national goal that ...